Comparison of adjusted overall survival probabilities with primary cancer patients in the general population
| Cancer type . | No. . | 3-y adjusted overall survival* . | Autologous vs general . | Allogeneic vs general . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| General . | Autologous . | Allogeneic . | General . | Autologous . | Allogeneic . | HR* (95% CI) . | P . | HR* (95% CI) . | P . | |
| All | 541 134 | 217 | 496 | 0.72 | 0.65 | 0.60 | 1.21 (0.96-1.53) | .11 | 1.41 (1.20-1.65) | <.001 |
| Oral cavity/pharynx | 7 904 | 8 | 109 | 0.65 | 0.85 | 0.62 | 0.55 (0.08-3.93) | .56 | 0.99 (0.65-1.49) | .95 |
| Esophagus | 13 804 | 7 | 76 | 0.42 | 0.47 | 0.34 | 0.61 (0.15-2.44) | .48 | 1.15 (0.83-1.60) | .40 |
| Stomach | 82 076 | 20 | 28 | 0.66 | 0.54 | 0.57 | 1.61 (0.76-3.37) | .21 | 1.37 (0.65-2.87) | .41 |
| Colon | 72 270 | 36 | 43 | 0.75 | 0.63 | 0.54 | 1.57 (0.85-2.92) | .15 | 2.14 (1.27-3.62) | .004 |
| Liver | 32 078 | 14 | 6 | 0.45 | 0.47 | 0.44 | 0.95 (0.43-2.12) | .91 | 1.32 (0.42-4.10) | .63 |
| Pancreas | 11 329 | 10 | 15 | 0.12 | 0.20 | 0.07 | 0.81 (0.34-1.95) | .64 | 1.24 (0.67-2.31) | .49 |
| Lung | 63 833 | 38 | 43 | 0.38 | 0.42 | 0.28 | 0.88 (0.55-1.42) | .60 | 1.12 (0.73-1.72) | .61 |
| Bone/soft tissue | 2 404 | 9 | 22 | 0.67 | 0.21 | 0.24 | 2.93 (1.21-7.07) | .017 | 3.16 (1.68-5.93) | <.001 |
| Skin | 5 582 | 4 | 24 | 0.88 | NA | 0.92 | NA | NA | 0.60 (0.08-4.27) | .61 |
| Breast | 50 155 | 14 | 24 | 0.93 | 0.91 | 0.90 | 1.35 (0.19-9.57) | .77 | 0.99 (0.14-7.07) | 1.0 |
| Cervix uteri | 6 459 | 1 | 8 | 0.81 | NA | 0.61 | NA | NA | 2.71 (0.67-10.9) | .16 |
| Corpus uteri | 7 298 | 4 | 9 | 0.87 | NA | 0.86 | NA | NA | 1.59 (0.22-11.5) | .65 |
| Prostate | 18 481 | 12 | 10 | 0.91 | 1.00 | 0.81 | NA | NA | 3.26 (0.46-23.2) | .24 |
| Kidney | 9 051 | 10 | 5 | 0.76 | 0.83 | 0.22 | 0.63 (0.09-4.51) | .65 | 2.27 (0.32-16.1) | .41 |
| Bladder | 6 959 | 7 | 12 | 0.78 | 1.00 | 0.72 | NA | NA | 0.74 (0.10-5.27) | .76 |
| Central nervous system | 750 | 2 | 14 | 0.27 | NA | 0.01 | NA | NA | 4.54 (2.29-9.01) | <.001 |
| Thyroid | 9 507 | 6 | 22 | 0.97 | 0.94 | 0.84 | 2.01 (0.27-14.8) | .49 | 4.47 (0.63-31.9) | .14 |
| Cancer type . | No. . | 3-y adjusted overall survival* . | Autologous vs general . | Allogeneic vs general . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| General . | Autologous . | Allogeneic . | General . | Autologous . | Allogeneic . | HR* (95% CI) . | P . | HR* (95% CI) . | P . | |
| All | 541 134 | 217 | 496 | 0.72 | 0.65 | 0.60 | 1.21 (0.96-1.53) | .11 | 1.41 (1.20-1.65) | <.001 |
| Oral cavity/pharynx | 7 904 | 8 | 109 | 0.65 | 0.85 | 0.62 | 0.55 (0.08-3.93) | .56 | 0.99 (0.65-1.49) | .95 |
| Esophagus | 13 804 | 7 | 76 | 0.42 | 0.47 | 0.34 | 0.61 (0.15-2.44) | .48 | 1.15 (0.83-1.60) | .40 |
| Stomach | 82 076 | 20 | 28 | 0.66 | 0.54 | 0.57 | 1.61 (0.76-3.37) | .21 | 1.37 (0.65-2.87) | .41 |
| Colon | 72 270 | 36 | 43 | 0.75 | 0.63 | 0.54 | 1.57 (0.85-2.92) | .15 | 2.14 (1.27-3.62) | .004 |
| Liver | 32 078 | 14 | 6 | 0.45 | 0.47 | 0.44 | 0.95 (0.43-2.12) | .91 | 1.32 (0.42-4.10) | .63 |
| Pancreas | 11 329 | 10 | 15 | 0.12 | 0.20 | 0.07 | 0.81 (0.34-1.95) | .64 | 1.24 (0.67-2.31) | .49 |
| Lung | 63 833 | 38 | 43 | 0.38 | 0.42 | 0.28 | 0.88 (0.55-1.42) | .60 | 1.12 (0.73-1.72) | .61 |
| Bone/soft tissue | 2 404 | 9 | 22 | 0.67 | 0.21 | 0.24 | 2.93 (1.21-7.07) | .017 | 3.16 (1.68-5.93) | <.001 |
| Skin | 5 582 | 4 | 24 | 0.88 | NA | 0.92 | NA | NA | 0.60 (0.08-4.27) | .61 |
| Breast | 50 155 | 14 | 24 | 0.93 | 0.91 | 0.90 | 1.35 (0.19-9.57) | .77 | 0.99 (0.14-7.07) | 1.0 |
| Cervix uteri | 6 459 | 1 | 8 | 0.81 | NA | 0.61 | NA | NA | 2.71 (0.67-10.9) | .16 |
| Corpus uteri | 7 298 | 4 | 9 | 0.87 | NA | 0.86 | NA | NA | 1.59 (0.22-11.5) | .65 |
| Prostate | 18 481 | 12 | 10 | 0.91 | 1.00 | 0.81 | NA | NA | 3.26 (0.46-23.2) | .24 |
| Kidney | 9 051 | 10 | 5 | 0.76 | 0.83 | 0.22 | 0.63 (0.09-4.51) | .65 | 2.27 (0.32-16.1) | .41 |
| Bladder | 6 959 | 7 | 12 | 0.78 | 1.00 | 0.72 | NA | NA | 0.74 (0.10-5.27) | .76 |
| Central nervous system | 750 | 2 | 14 | 0.27 | NA | 0.01 | NA | NA | 4.54 (2.29-9.01) | <.001 |
| Thyroid | 9 507 | 6 | 22 | 0.97 | 0.94 | 0.84 | 2.01 (0.27-14.8) | .49 | 4.47 (0.63-31.9) | .14 |
NA, not applicable.
Adjusted for patient sex, patient age at cancer diagnosis, year of cancer diagnosis, and cancer type. Hazard ratios and P values were derived from multivariable Cox models.